Actualités connexes
Algonquin Power ne passe toujours pas, selon iA Capital Markets
de lecture
Disponible en anglais seulement.
iA Capital Markets analyst Naji Baydoun is still skeptical about Algonquin Power & Utilities (Algonquin Power & Utilities Stock Quote, Charts, News, Analysts, Financials TSX:AQN), saying in a review of the company’s latest quarterly numbers that investors should wait to see how well the utility company fares on this year’s strategic priorities.
En savoir plus.
Source : Cantech Letter
Acheter Innergex dans le secteur de l'énergie renouvelable, affirme iA Marchés des capitaux.
de lecture
Disponible en anglais seulement.
iA Capital Markets analyst Naji Baydoun delivered an update on Friday on Innergex Renewable Energy (Innergex Renewable Energy Stock Quote, Charts, News, Analysts, Financials TSE:INE) where he reviewed the company’s just-released fourth quarter results, saying the company has a strong growth outlook and declining payout ratio.
En savoir plus.
Source: Cantech Letter
Exchange Income Corp obtient une augmentation cible de iA Marchés des capitaux.
de lecture
Disponible en anglais seulement.
Organic and inorganic growth as well as higher margins look to be in the cards for Exchange Income Corp (Exchange Income Stock Quote, Charts, News, Analysts, Financials TSX:EIF), according to iA Capital Markets analyst Matthew Weekes.
En savoir plus.
Source: Cantech Letter
Arch Biopartners se dirige vers un prix de 6 $, selon iA Marchés des capitaux.
de lecture
Disponible en anglais seulement.
iA Capital Markets analyst Chelsea Stellick is staying bullish on Canadian biotech company Arch Biopartners (Arch Biopartners Stock Quote, Charts, News, Analysts, Financials TSXV:ARCH), saying in a Tuesday report that the company is ready to ramp up its clinical development programs.
En savoir plus.
Source: Cantech Letter
iA Marchés des capitaux reste optimiste quant à Dialogue Technologies de la Santé
de lecture
Disponible en anglais seulement.
iA Capital Markets analyst Chelsea Stellick keeps talking up Dialogue Health Technologies (Dialogue Health Technologies Stock Quote, Charts, News, Analysts, Financials TSX:CARE) in a Wednesday report to clients where she maintained a “Buy” rating on the stock.
En savoir plus.
Source : Cantech Letter